Phone us

The main objective of DNV’s biorisk services is to strengthen our biorisk knowledge and networks while also developing biorisk specific methodologies and tools to help our customers effectively manage the biorisks within their organisation. At DNV, we use risk-based approach to identify the hazards and risk associated with biological agents and its products, and also ensure appropriate biorisk controls are identified and implemented in organisations wishing to operate their laboratories in safety and responsibly.
Facility risk assessments have an enormous potential to improve the safety of a laboratory facility by recognising and eliminating potential problems at the design stage. A number of recognised approaches can be used and this includes SWIFT, HAZOP, AR&M and SIL studies.
AR&M (availability, reliability & maintainability) studies are used to compare alternative designs, maintenance approaches and operating strategies. A detailed understanding of the facility systems or processes is obtained by evaluating the main contributors to failure scenarios.
DNV has designed a series of training courses to provide laboratory managers, biosafety personnel and scientific staff with the required skills and aptitudes necessary to effectively manage biorisk.
DNV has developed a systematic approach to evaluate the safety integrity levels (SIL) required for safety related systems containment facilities, equipment and associated processes. The methodology can be applied at any stage of the design lifecycle and provides a practical way of demonstrating risk acceptability, including compliance with legislative requirements.
HAZOP is a well known hazard identification technique that ensures comprehensive and systematic coverage of all the relevant areas in the initial design or change of a facility. During a HAZOP the review team searches the design, looking for process deviations and assessing their impact.
Accidents can occur when carrying out simple, daily tasks within the laboratory. Workers can face many hazards on a daily basis from chemicals, radioactivity, physical hazards (eg, trips hazards, heavy objects), electricity, and of course biological agents themselves. Task risk assessment is an essential part of biosafety management in the laboratory.
Commissioning and validation provides assurance that all relevant measures in the specification have been incorporated into the finished facility.

A new strain of influenza virus is spreading around the world causing public health concerns, costly disruption to business and anxiety to individuals and their families. In such a situation, understanding the prevention and control of infection is essential for the well-being and safety of the staff, family and community.

The management of biosafety and biosecurity (collectively know as biorisk) have become a vital global issue, especially in light of the laboratory-acquired cases of SARS in Singapore, Taiwan and China in 2004.

Indonesia is now the country with the highest number of human fatalities caused by the H5N1 influenza virus, often referred to as ‘avian flu’. In an effort to tackle the deadly disease, the prestigious Eijkman Institute in Jakarta has built a new biosafety level 3 (BSL3) laboratory – with the help of DNV.

The Agency for Science, Technology and Research (A*STAR) is leading the way in biomedical research – with the help of DNV.